NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older

Diabetes

Volumn 52, Issue 5, 2003, Pages 1210-1214

  Alexander, Charles M ^a   Landsman, Pamela B ^a   Teutsch, Steven M ^a   Haffner, Steven M ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

AGE FACTORS; BLOOD PRESSURE; BODY CONSTITUTION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT EDUCATION; PHYSICAL EXAMINATION; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SMOKING; UNITED STATES;

EID: 0037407403     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.5.1210     Document Type: Article

References (31)

1. Avogaro P, Crepaldi G, Enzi G, Tiengo A: Associazione di iperlipidemia, diabete mellito e obesità di medio grado. Acta Diabetol Lat 4:36-41, 1967
2. Haller H: Epidemiologie und assoziierte Risikofaktoren der Hyperlipoproteinamie [Epidemiology and associated risk factors of hyperlipoproteinemia]. Z Gesamte Inn Med 32:124-128, 1977
3. Singer P: Zur Diagnostik der primaren Hyperlipoproteinamien [Diagnosis of primary hyperlipoproteinemias]. Z Gesamte Inn Med 32:129-133, 1977
4. Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
5. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
6. Reaven GM: Syndrome X. Blood Press Suppl 4:13-16, 1992
7. Meigs JB, D'Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE: Risk variable clustering in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes 46:1594-1600, 1997
8. Gerstein HC: Is glucose a continuous risk factor for cardiovascular mortality? Diabetes Care 22:659-660, 1999
9. DECODE Study Group: Glucose tolerance and cardiovascular mortality. Arch Intern Med 161:397-404, 2001
10. DECODE Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617-621, 1999
11. Haffner SM: Impaired glucose tolerance: is it relevant for cardiovascular disease? Diabetologia 40 (Suppl. 2):S138-S140, 1997
12. Balkau B, Shipley M, Jarrett RJ, Pyörälä K, Pyörälä M, Forhan A, Eschwege E: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policeman Study. Diabetes Care 21:360-367, 1998
13. Meigs JB, Nathan DM, Wilson PW, Cupples LA, Singer DE: Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: the Framingham Offspring Study. Ann Intern Med 128:524-533, 1998
14. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689, 2001
15. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Lupien PJ, Despres JP: Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279:1955-1961, 1998
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
17. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
18. National Center for Health Statistics: Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, MD, National Center for Health Statistics, 1994 (Vital and Health Statistics Series 1, no. 32)
19. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey 1988-1994. Diabetes Care. 21:518-524, 1998
20. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 209:1183-1197, 1997
21. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
22. McAuley K, Williams S, Mann J, Walker R, Lewis-Barned N, Temple L, Duncan A: Diagnosing insulin resistance in the general population. Diabetes Care 24:460-464, 2001
23. Haffner S, Miettinen H, Stern M: The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087-1092, 1997
24. Rose GA, Blackburn H, Gillium RF, Prineas RJ: Cardiovascular Survey Methods. 2nd ed. Geneva, Switzerland, World Health Organization, 1982
25. Statistical Analysis Systems (SAS) version 8e for PC. SAS Institute Inc., Cary, NC
26. Software for survey design analysis (SUDAAN) version 7.5.3. Research Triangle Institute, Research Triangle Park, NC, 1998
27. Stout RW: Hyperinsulinemia and atherosclerosis. Diabetes 45 (Suppl. 3):S45-S46, 1996
28. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47, 2000
29. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
30. Alexander CM, Landsman PB, Teutsch SM: Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol 86:897-902, 2000
31. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195-1200, 2001